|
DMXL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.05360009184619E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.98010002733429E-09 |
| Normal-vs-Stage2 |
3.480000E-03 |
| Normal-vs-Stage3 |
9.00579999463247E-09 |
| Normal-vs-Stage4 |
7.94864174480381E-12 |
| Stage1-vs-Stage2 |
9.700300E-02 |
| Stage1-vs-Stage3 |
2.195000E-01 |
| Stage1-vs-Stage4 |
1.719550E-03 |
| Stage2-vs-Stage3 |
3.159800E-02 |
| Stage2-vs-Stage4 |
8.612300E-04 |
| Stage3-vs-Stage4 |
8.441600E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.35309985438425E-10 |
| Normal-vs-AfricanAmerican |
1.204150E-02 |
| Normal-vs-Asian |
2.12359999585132E-08 |
| Caucasian-vs-AfricanAmerican |
5.640400E-01 |
| Caucasian-vs-Asian |
6.523200E-01 |
| AfricanAmerican-vs-Asian |
4.398000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.72990000102402E-08 |
| Normal-vs-Female |
3.46460005129501E-09 |
| Male-vs-Female |
9.912600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.96690003068301E-09 |
| Normal-vs-Age(41-60Yrs) |
1.89440000353258E-08 |
| Normal-vs-Age(61-80Yrs) |
7.84120000041355E-07 |
| Normal-vs-Age(81-100Yrs) |
6.918700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.100800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.856200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.754600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.165000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.564200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.145800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.096400E-02 |
| Classical-VS-Follicular |
1.021640E-04 |
| Classical-VS-Other |
5.613800E-01 |
| Classical-VS-Normal |
1.35850219962208E-11 |
| Tall-VS-Follicular |
4.357599999949E-06 |
| Tall-VS-Other |
8.364300E-02 |
| Tall-VS-Normal |
5.36190003508352E-09 |
| Follicular-VS-Other |
1.006620E-01 |
| Follicular-VS-Normal |
4.695900E-02 |
| Other-VS-Normal |
3.331600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.4600000003705E-07 |
| Normal-vs-N1 |
1.50790002706458E-09 |
| N0-vs-N1 |
8.400000E-02 |
|
|
